Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F de Wolf

Showing results (201-210 of 219) with videos related to

Pageof 22
Sort By:
Journal of Vascular and Interventional Radiology : JVIR|December 11, 2024
Venous Stents Placed for Postthrombotic Syndrome: The Role of Inflow Disease on PatencyJay M Bakas, Mark A F de Wolf, Renate R van den Bos, et al.
AIDS (London, England)|February 10, 1998
Improvement of chronic diarrhoea in patients with advanced HIV-1 infection during potent antiretroviral therapyN A Foudraine, G J Weverling, T van Gool, et al.
Science (New York, N.Y.)|November 29, 1996
T cell telomere length in HIV-1 infection: no evidence for increased CD4+ T cell turnoverK C Wolthers, G Bea, A Wisman, et al.
Annals of Internal Medicine|February 12, 1998
Association between CCR5 genotype and the clinical course of HIV-1 infectionA M de Roda Husman, M Koot, M Cornelissen, et al.
Lancet (London, England)|July 31, 1998
Maintenance therapy after quadruple induction therapy in HIV-1 infected individuals: Amsterdam Duration of Antiretroviral Medication (ADAM) studyM H Reijers, G J Weverling, S Jurriaans, et al.
Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|July 5, 2011
Stability, survival, and tolerability of a novel baha implant system: six-month data from a multicenter clinical investigationCatharina A J Dun, Maarten J F de Wolf, Myrthe K S Hol, et al.
Nederlands Tijdschrift Voor Geneeskunde|February 27, 1999
[Amsterdam duration of antiretroviral medication (ADAM)--study: induction-suppression treatment in HIV-I infection, preliminary results]M H Reijers, G J Weverling, S Jurriaans, et al.
AIDS (London, England)|February 19, 1998
Decrease of HIV-1 RNA levels in lymphoid tissue and peripheral blood during treatment with ritonavir, lamivudine and zidovudine. Ritonavir/3TC/ZDV Study GroupD W Notermans, S Jurriaans, F de Wolf, et al.
The Journal of Clinical Investigation|December 31, 1997
Selective inhibition of syncytium-inducing and nonsyncytium-inducing HIV-1 variants in individuals receiving didanosine or zidovudine, respectivelyA B van't Wout, L J Ran, M D de Jong, et al.
HIV Medicine|March 12, 2004
Differential CD4 T-cell response in HIV-1-infected patients using protease inhibitor-based or nevirapine-based highly active antiretroviral therapyF van Leth, F W N M Wit, P Reiss, et al.
Pageof 22

Showing results (201-210 of 219) with videos related to

Sort By:
Pageof 22
Journal of Vascular and Interventional Radiology : JVIR|December 11, 2024
Venous Stents Placed for Postthrombotic Syndrome: The Role of Inflow Disease on PatencyJay M Bakas, Mark A F de Wolf, Renate R van den Bos, et al.
AIDS (London, England)|February 10, 1998
Improvement of chronic diarrhoea in patients with advanced HIV-1 infection during potent antiretroviral therapyN A Foudraine, G J Weverling, T van Gool, et al.
Science (New York, N.Y.)|November 29, 1996
T cell telomere length in HIV-1 infection: no evidence for increased CD4+ T cell turnoverK C Wolthers, G Bea, A Wisman, et al.
Annals of Internal Medicine|February 12, 1998
Association between CCR5 genotype and the clinical course of HIV-1 infectionA M de Roda Husman, M Koot, M Cornelissen, et al.
Lancet (London, England)|July 31, 1998
Maintenance therapy after quadruple induction therapy in HIV-1 infected individuals: Amsterdam Duration of Antiretroviral Medication (ADAM) studyM H Reijers, G J Weverling, S Jurriaans, et al.
Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|July 5, 2011
Stability, survival, and tolerability of a novel baha implant system: six-month data from a multicenter clinical investigationCatharina A J Dun, Maarten J F de Wolf, Myrthe K S Hol, et al.
Nederlands Tijdschrift Voor Geneeskunde|February 27, 1999
[Amsterdam duration of antiretroviral medication (ADAM)--study: induction-suppression treatment in HIV-I infection, preliminary results]M H Reijers, G J Weverling, S Jurriaans, et al.
AIDS (London, England)|February 19, 1998
Decrease of HIV-1 RNA levels in lymphoid tissue and peripheral blood during treatment with ritonavir, lamivudine and zidovudine. Ritonavir/3TC/ZDV Study GroupD W Notermans, S Jurriaans, F de Wolf, et al.
The Journal of Clinical Investigation|December 31, 1997
Selective inhibition of syncytium-inducing and nonsyncytium-inducing HIV-1 variants in individuals receiving didanosine or zidovudine, respectivelyA B van't Wout, L J Ran, M D de Jong, et al.
HIV Medicine|March 12, 2004
Differential CD4 T-cell response in HIV-1-infected patients using protease inhibitor-based or nevirapine-based highly active antiretroviral therapyF van Leth, F W N M Wit, P Reiss, et al.
Pageof 22